[{'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'BUDESONIDE', 'product_number': 1, 'trade_name': 'UCERIS', 'owner_name': 'VALEANT PHARMACEUTICALS INTERNATIONAL', 'delivery_method': 'RECTAL', 'drug_strength': '2MG/ACTUATION', 'patent_number': '5914122', 'drug_application_number': 205613, 'approval_date': 'Oct 7, 2014', 'patent_expiration_date': 'Dec 19, 2015'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'ECONAZOLE NITRATE', 'product_number': 1, 'trade_name': 'ECOZA', 'owner_name': 'EXELTIS SUISSE SA', 'delivery_method': 'TOPICAL', 'drug_strength': '1%', 'patent_number': '5993830', 'drug_application_number': 205175, 'approval_date': 'Oct 24, 2013', 'patent_expiration_date': 'Jan 16, 2018'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE', 'product_number': 1, 'trade_name': 'ENSTILAR', 'owner_name': 'LEO PHARMA AS', 'delivery_method': 'TOPICAL', 'drug_strength': '0.064%;0.005%', 'patent_number': '6753013', 'drug_application_number': 207589, 'approval_date': 'Oct 16, 2015', 'patent_expiration_date': 'Jan 27, 2020'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE', 'product_number': 1, 'trade_name': 'ENSTILAR', 'owner_name': 'LEO PHARMA AS', 'delivery_method': 'TOPICAL', 'drug_strength': '0.064%;0.005%', 'patent_number': '9119781', 'drug_application_number': 207589, 'approval_date': 'Oct 16, 2015', 'patent_expiration_date': 'Jun 10, 2031'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CLINDAMYCIN PHOSPHATE', 'product_number': 1, 'trade_name': 'EVOCLIN', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '1%', 'patent_number': '7141237', 'drug_application_number': 50801, 'approval_date': 'Oct 22, 2004', 'patent_expiration_date': 'Jan 23, 2024'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CLINDAMYCIN PHOSPHATE', 'product_number': 1, 'trade_name': 'EVOCLIN', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '1%', 'patent_number': '7374747', 'drug_application_number': 50801, 'approval_date': 'Oct 22, 2004', 'patent_expiration_date': 'Aug 9, 2026'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'KETOCONAZOLE', 'product_number': 1, 'trade_name': 'EXTINA', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '2%', 'patent_number': '7553835', 'drug_application_number': 21738, 'approval_date': 'Jun 12, 2007', 'patent_expiration_date': 'Oct 19, 2018'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'KETOCONAZOLE', 'product_number': 1, 'trade_name': 'EXTINA', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '2%', 'patent_number': '8026238', 'drug_application_number': 21738, 'approval_date': 'Jun 12, 2007', 'patent_expiration_date': 'Oct 19, 2018'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'TAZAROTENE', 'product_number': 1, 'trade_name': 'FABIOR', 'owner_name': 'STIEFEL LABORATORIES INC', 'delivery_method': 'TOPICAL', 'drug_strength': '0.1%', 'patent_number': '8808716', 'drug_application_number': 202428, 'approval_date': 'May 11, 2012', 'patent_expiration_date': 'Feb 24, 2030'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'AZELAIC ACID', 'product_number': 1, 'trade_name': 'FINACEA ', 'owner_name': 'BAYER HEALTHCARE PHARMACEUTICALS INC', 'delivery_method': 'TOPICAL', 'drug_strength': '15%', 'patent_number': '6730288', 'drug_application_number': 207071, 'approval_date': 'Jul 29, 2015', 'patent_expiration_date': 'Sep 8, 2019'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'AZELAIC ACID', 'product_number': 1, 'trade_name': 'FINACEA ', 'owner_name': 'BAYER HEALTHCARE PHARMACEUTICALS INC', 'delivery_method': 'TOPICAL', 'drug_strength': '15%', 'patent_number': '7700076', 'drug_application_number': 207071, 'approval_date': 'Jul 29, 2015', 'patent_expiration_date': 'Sep 18, 2027'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'AZELAIC ACID', 'product_number': 1, 'trade_name': 'FINACEA ', 'owner_name': 'BAYER HEALTHCARE PHARMACEUTICALS INC', 'delivery_method': 'TOPICAL', 'drug_strength': '15%', 'patent_number': '8435498', 'drug_application_number': 207071, 'approval_date': 'Jul 29, 2015', 'patent_expiration_date': 'Mar 1, 2024'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'AZELAIC ACID', 'product_number': 1, 'trade_name': 'FINACEA ', 'owner_name': 'BAYER HEALTHCARE PHARMACEUTICALS INC', 'delivery_method': 'TOPICAL', 'drug_strength': '15%', 'patent_number': '8722021', 'drug_application_number': 207071, 'approval_date': 'Jul 29, 2015', 'patent_expiration_date': 'Oct 24, 2023'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'AZELAIC ACID', 'product_number': 1, 'trade_name': 'FINACEA ', 'owner_name': 'BAYER HEALTHCARE PHARMACEUTICALS INC', 'delivery_method': 'TOPICAL', 'drug_strength': '15%', 'patent_number': '8900554', 'drug_application_number': 207071, 'approval_date': 'Jul 29, 2015', 'patent_expiration_date': 'Oct 24, 2023'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'AZELAIC ACID', 'product_number': 1, 'trade_name': 'FINACEA ', 'owner_name': 'BAYER HEALTHCARE PHARMACEUTICALS INC', 'delivery_method': 'TOPICAL', 'drug_strength': '15%', 'patent_number': '9211259', 'drug_application_number': 207071, 'approval_date': 'Jul 29, 2015', 'patent_expiration_date': 'Jan 26, 2029'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'AZELAIC ACID', 'product_number': 1, 'trade_name': 'FINACEA ', 'owner_name': 'BAYER HEALTHCARE PHARMACEUTICALS INC', 'delivery_method': 'TOPICAL', 'drug_strength': '15%', 'patent_number': '9265725', 'drug_application_number': 207071, 'approval_date': 'Jul 29, 2015', 'patent_expiration_date': 'Dec 8, 2027'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'BETAMETHASONE VALERATE', 'product_number': 1, 'trade_name': 'LUXIQ', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '0.12%', 'patent_number': '6126920', 'drug_application_number': 20934, 'approval_date': 'Feb 28, 1999', 'patent_expiration_date': 'Mar 1, 2016'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'BETAMETHASONE VALERATE', 'product_number': 1, 'trade_name': 'LUXIQ', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '0.12%', 'patent_number': '7078058', 'drug_application_number': 20934, 'approval_date': 'Feb 28, 1999', 'patent_expiration_date': 'May 24, 2017'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'MINOXIDIL', 'product_number': 1, 'trade_name': "MEN'S ROGAINE", 'owner_name': 'JOHNSON AND JOHNSON GROUP CONSUMER COMPANIES', 'delivery_method': 'TOPICAL', 'drug_strength': '5%', 'patent_number': '6946120', 'drug_application_number': 21812, 'approval_date': 'Jan 20, 2006', 'patent_expiration_date': 'Apr 20, 2019'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'MINOXIDIL', 'product_number': 1, 'trade_name': "MEN'S ROGAINE", 'owner_name': 'JOHNSON AND JOHNSON GROUP CONSUMER COMPANIES', 'delivery_method': 'TOPICAL', 'drug_strength': '5%', 'patent_number': '6946120', 'drug_application_number': 21812, 'approval_date': 'Jan 20, 2006', 'patent_expiration_date': 'Apr 20, 2019'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CLOBETASOL PROPIONATE', 'product_number': 1, 'trade_name': 'OLUX', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '0.05%', 'patent_number': '6126920', 'drug_application_number': 21142, 'approval_date': 'May 26, 2000', 'patent_expiration_date': 'Mar 1, 2016'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CLOBETASOL PROPIONATE', 'product_number': 1, 'trade_name': 'OLUX E', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '0.05%', 'patent_number': '6730288', 'drug_application_number': 22013, 'approval_date': 'Jan 12, 2007', 'patent_expiration_date': 'Sep 8, 2019'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CLOBETASOL PROPIONATE', 'product_number': 1, 'trade_name': 'OLUX E', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '0.05%', 'patent_number': '7029659', 'drug_application_number': 22013, 'approval_date': 'Jan 12, 2007', 'patent_expiration_date': 'Sep 8, 2019'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CLOBETASOL PROPIONATE', 'product_number': 1, 'trade_name': 'OLUX E', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '0.05%', 'patent_number': '8460641', 'drug_application_number': 22013, 'approval_date': 'Jan 12, 2007', 'patent_expiration_date': 'Nov 5, 2028'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CLOBETASOL PROPIONATE', 'product_number': 1, 'trade_name': 'OLUX E', 'owner_name': 'DELCOR ASSET CORP', 'delivery_method': 'TOPICAL', 'drug_strength': '0.05%', 'patent_number': '8962000', 'drug_application_number': 22013, 'approval_date': 'Jan 12, 2007', 'patent_expiration_date': 'Aug 31, 2025'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CALCIPOTRIENE', 'product_number': 1, 'trade_name': 'SORILUX', 'owner_name': 'STIEFEL LABORATORIES INC', 'delivery_method': 'TOPICAL', 'drug_strength': '0.005%', 'patent_number': '8263580', 'drug_application_number': 22563, 'approval_date': 'Oct 6, 2010', 'patent_expiration_date': 'Sep 27, 2028'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CALCIPOTRIENE', 'product_number': 1, 'trade_name': 'SORILUX', 'owner_name': 'STIEFEL LABORATORIES INC', 'delivery_method': 'TOPICAL', 'drug_strength': '0.005%', 'patent_number': '8629128', 'drug_application_number': 22563, 'approval_date': 'Oct 6, 2010', 'patent_expiration_date': 'May 26, 2026'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'CALCIPOTRIENE', 'product_number': 1, 'trade_name': 'SORILUX', 'owner_name': 'STIEFEL LABORATORIES INC', 'delivery_method': 'TOPICAL', 'drug_strength': '0.005%', 'patent_number': '8629128', 'drug_application_number': 22563, 'approval_date': 'Oct 6, 2010', 'patent_expiration_date': 'May 26, 2026'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'DESONIDE', 'product_number': 1, 'trade_name': 'VERDESO', 'owner_name': 'AQUA PHARMACEUTICALS', 'delivery_method': 'TOPICAL', 'drug_strength': '0.05%', 'patent_number': '6730288', 'drug_application_number': 21978, 'approval_date': 'Sep 19, 2006', 'patent_expiration_date': 'Sep 8, 2019'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'DESONIDE', 'product_number': 1, 'trade_name': 'VERDESO', 'owner_name': 'AQUA PHARMACEUTICALS', 'delivery_method': 'TOPICAL', 'drug_strength': '0.05%', 'patent_number': '7029659', 'drug_application_number': 21978, 'approval_date': 'Sep 19, 2006', 'patent_expiration_date': 'Sep 8, 2019'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'DESONIDE', 'product_number': 1, 'trade_name': 'VERDESO', 'owner_name': 'AQUA PHARMACEUTICALS', 'delivery_method': 'TOPICAL', 'drug_strength': '0.05%', 'patent_number': '8460641', 'drug_application_number': 21978, 'approval_date': 'Sep 19, 2006', 'patent_expiration_date': 'Nov 5, 2028'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'DESONIDE', 'product_number': 1, 'trade_name': 'VERDESO', 'owner_name': 'AQUA PHARMACEUTICALS', 'delivery_method': 'TOPICAL', 'drug_strength': '0.05%', 'patent_number': '8962000', 'drug_application_number': 21978, 'approval_date': 'Sep 19, 2006', 'patent_expiration_date': 'Aug 31, 2025'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'MINOXIDIL', 'product_number': 2, 'trade_name': "WOMEN'S ROGAINE", 'owner_name': 'JOHNSON AND JOHNSON GROUP CONSUMER COMPANIES', 'delivery_method': 'TOPICAL', 'drug_strength': '5%', 'patent_number': '6946120', 'drug_application_number': 21812, 'approval_date': 'Feb 28, 2014', 'patent_expiration_date': 'Apr 20, 2019'}, {'dosage_type': 'AEROSOL, FOAM', 'ingredient': 'MINOXIDIL', 'product_number': 2, 'trade_name': "WOMEN'S ROGAINE", 'owner_name': 'JOHNSON AND JOHNSON GROUP CONSUMER COMPANIES', 'delivery_method': 'TOPICAL', 'drug_strength': '5%', 'patent_number': '6946120', 'drug_application_number': 21812, 'approval_date': 'Feb 28, 2014', 'patent_expiration_date': 'Apr 20, 2019'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6161724', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jan 16, 2018'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6161724', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jan 16, 2018'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6161724', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jan 16, 2018'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6161724*PED', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jul 16, 2018'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6161724*PED', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jul 16, 2018'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6161724*PED', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jul 16, 2018'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6170717', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Dec 23, 2017'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6170717', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Dec 23, 2017'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6170717', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Dec 23, 2017'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6170717*PED', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jun 23, 2018'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6170717*PED', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jun 23, 2018'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6170717*PED', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jun 23, 2018'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6315173', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Dec 23, 2017'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6315173', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Dec 23, 2017'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6315173', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Dec 23, 2017'}, {'dosage_type': 'AEROSOL, METERED', 'ingredient': 'FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE', 'product_number': 1, 'trade_name': 'ADVAIR HFA', 'owner_name': 'GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE', 'delivery_method': 'INHALATION', 'drug_strength': '0.045MG/INH;EQ 0.021MG BASE/INH', 'patent_number': '6315173*PED', 'drug_application_number': 21254, 'approval_date': 'Jun 8, 2006', 'patent_expiration_date': 'Jun 23, 2018'}]